Counterpoints: Should treatment for CML continue indefinitely?

Nicholas J. Short, Elias Jabbour, Gabriel Etienne, François Xavier Mahon

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Counterpoints: Should treatment for CML continue indefinitely?'. Together they form a unique fingerprint.